SH-L-749
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SH-L-749, covering 2014-12-30 to 2014-12-30. Get the full timeline:
Most recent: Clinical Trial Update: Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma [Phase 2]